These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 29207103

  • 1. Epigenetic alterations of the Igf2 promoter and the effect of miR‑483‑5p on its target gene expression in esophageal squamous cell carcinoma.
    Zhang H, Shi X, Chang W, Li Y, Wang L, Wang L.
    Mol Med Rep; 2018 Feb; 17(2):2251-2256. PubMed ID: 29207103
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-615-5p targets insulin-like growth factor 2 and exerts tumor-suppressing functions in human esophageal squamous cell carcinoma.
    Yang B, Xie R, Wu SN, Gao CC, Yang XZ, Zhou JF.
    Oncol Rep; 2018 Jan; 39(1):255-263. PubMed ID: 29115555
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells.
    Yu T, Cao R, Li S, Fu M, Ren L, Chen W, Zhu H, Zhan Q, Shi R.
    BMC Cancer; 2015 Jan 31; 15():29. PubMed ID: 25637514
    [Abstract] [Full Text] [Related]

  • 5. DNMT1-microRNA126 epigenetic circuit contributes to esophageal squamous cell carcinoma growth via ADAM9-EGFR-AKT signaling.
    Liu R, Gu J, Jiang P, Zheng Y, Liu X, Jiang X, Huang E, Xiong S, Xu F, Liu G, Ge D, Chu Y.
    Clin Cancer Res; 2015 Feb 15; 21(4):854-63. PubMed ID: 25512445
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.
    Liu Y, Dong Z, Liang J, Guo Y, Guo X, Shen S, Kuang G, Guo W.
    Tumour Biol; 2016 Apr 15; 37(4):5621-32. PubMed ID: 26577858
    [Abstract] [Full Text] [Related]

  • 8. H19 DMR methylation correlates to the progression of esophageal squamous cell carcinoma through IGF2 imprinting pathway.
    Gao T, He B, Pan Y, Gu L, Chen L, Nie Z, Xu Y, Li R, Wang S.
    Clin Transl Oncol; 2014 Apr 15; 16(4):410-7. PubMed ID: 23943562
    [Abstract] [Full Text] [Related]

  • 9. Upregulation of the long noncoding RNA PCAT-1 correlates with advanced clinical stage and poor prognosis in esophageal squamous carcinoma.
    Shi WH, Wu QQ, Li SQ, Yang TX, Liu ZH, Tong YS, Tuo L, Wang S, Cao XF.
    Tumour Biol; 2015 Apr 15; 36(4):2501-7. PubMed ID: 25731728
    [Abstract] [Full Text] [Related]

  • 10. Decreased expression of retinoblastoma protein-interacting zinc-finger gene 1 in human esophageal squamous cell cancer by DNA methylation.
    Dong SW, Cui YT, Zhong RR, Liang DC, Liu YM, Wang YG, He Z, Wang S, Liang SJ, Zhang P.
    Clin Lab; 2012 Apr 15; 58(1-2):41-51. PubMed ID: 22372344
    [Abstract] [Full Text] [Related]

  • 11. Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma.
    Li P, Liu X, Dong ZM, Ling ZQ.
    Oncotarget; 2015 Nov 10; 6(35):38151-65. PubMed ID: 26510908
    [Abstract] [Full Text] [Related]

  • 12. miR612 is associated with esophageal squamous cell carcinoma development and metastasis, mediated through TP53.
    Zhou P, Dong H, He S, Fang L, Jiang N, Sun Q.
    Mol Med Rep; 2017 Aug 10; 16(2):1855-1863. PubMed ID: 28656264
    [Abstract] [Full Text] [Related]

  • 13. Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma.
    Hu L, Wu Y, Tan D, Meng H, Wang K, Bai Y, Yang K.
    J Exp Clin Cancer Res; 2015 Jan 22; 34(1):7. PubMed ID: 25613496
    [Abstract] [Full Text] [Related]

  • 14. IGF2 DMR0 methylation, loss of imprinting, and patient prognosis in esophageal squamous cell carcinoma.
    Murata A, Baba Y, Watanabe M, Shigaki H, Miyake K, Ishimoto T, Iwatsuki M, Iwagami S, Yoshida N, Oki E, Morita M, Nakao M, Baba H.
    Ann Surg Oncol; 2014 Apr 22; 21(4):1166-74. PubMed ID: 24318096
    [Abstract] [Full Text] [Related]

  • 15. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
    Wang C, Li Z, Shao F, Yang X, Feng X, Shi S, Gao Y, He J.
    J Exp Clin Cancer Res; 2017 Jun 23; 36(1):84. PubMed ID: 28645305
    [Abstract] [Full Text] [Related]

  • 16. [MiRNA224 Regulation Role on RKIP Gene Expression and Methylation of miRNA224 Gene Promoter Region in Esophageal Squamous Cell Carcinoma].
    Niu ZX, Yang XL, Liu MJ, Hu KF, Chen LH, Liu J.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Jul 23; 47(4):468-472. PubMed ID: 28591944
    [Abstract] [Full Text] [Related]

  • 17. BRCA1-Associated Protein Increases Invasiveness of Esophageal Squamous Cell Carcinoma.
    Zhao Y, Wei L, Shao M, Huang X, Chang J, Zheng J, Chu J, Cui Q, Peng L, Luo Y, Tan W, Tan W, Lin D, Wu C.
    Gastroenterology; 2017 Nov 23; 153(5):1304-1319.e5. PubMed ID: 28780075
    [Abstract] [Full Text] [Related]

  • 18. microRNA-195-Cdc42 axis acts as a prognostic factor of esophageal squamous cell carcinoma.
    Sun N, Ye L, Chang T, Li X, Li X.
    Int J Clin Exp Pathol; 2014 Nov 23; 7(10):6871-9. PubMed ID: 25400770
    [Abstract] [Full Text] [Related]

  • 19. FOXQ1 promotes esophageal cancer proliferation and metastasis by negatively modulating CDH1.
    Pei Y, Wang P, Liu H, He F, Ming L.
    Biomed Pharmacother; 2015 Aug 23; 74():89-94. PubMed ID: 26349968
    [Abstract] [Full Text] [Related]

  • 20. Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus.
    Hibino S, Kanda M, Oya H, Takami H, Shimizu D, Nomoto S, Hishida M, Niwa Y, Koike M, Yamada S, Nishikawa Y, Asai M, Nakayama G, Fujii T, Sugimoto H, Fujiwara M, Kodera Y.
    Oncol Rep; 2014 Feb 23; 31(2):693-700. PubMed ID: 24317529
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.